AngioDynamics, Inc. (OQ:ANGO)

Business Focus: Medical Equipment, Supplies & Distribution

Latest 10 SEC filings (by transaction date) for ANGO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/24 Feb 29/24 Trowbridge Stephen A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,927 $4.67
Jul 25/23 Jul 21/23 Trowbridge Stephen A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -667 $8.65
Jul 25/23 Jul 21/23 Clemmer James C Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,372 $8.65
Jul 25/23 Jul 21/23 Helsel Dave Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -365 $8.65
Jul 25/23 Jul 21/23 Centea Scott Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -255 $8.65
Jul 25/23 Jul 21/23 Piccinini Laura Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -413 $8.65
Jul 25/23 Jul 21/23 Campbell Chad Thomas Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -395 $8.65
Jul 25/23 Jul 20/23 Trowbridge Stephen A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -717 $8.74
Jul 25/23 Jul 20/23 Clemmer James C Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,982 $8.74
Jul 25/23 Jul 20/23 Helsel Dave Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -332 $8.74
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for ANGO within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET March 28th, 2024
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Mar 4/24 Feb 29/24 Trowbridge Stephen A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 1,927 $4.67
Sep 21/23 Jul 19/23 Trowbridge Stephen A Direct Ownership Performance Right M - Exercise or conversion exempt under rule 16b-3 -30,242  
Sep 21/23 Jul 19/23 Trowbridge Stephen A Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -6,975 $8.92
Sep 21/23 Jul 19/23 Trowbridge Stephen A Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 19,354  
Sep 21/23 Jul 19/23 Helsel Dave Direct Ownership Performance Right M - Exercise or conversion exempt under rule 16b-3 -15,081  
Sep 21/23 Jul 19/23 Helsel Dave Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,477 $8.92
Sep 21/23 Jul 19/23 Helsel Dave Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 9,650  
Sep 21/23 Jul 19/23 Centea Scott Direct Ownership Performance Right M - Exercise or conversion exempt under rule 16b-3 -11,782  
Sep 21/23 Jul 19/23 Centea Scott Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -2,716 $8.92
Sep 21/23 Jul 19/23 Centea Scott Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 7,539  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $ANGO

  • No tweets found

Competitors

Competitors with Recent Insider Filings
Cencora (N:COR)
DexCom (OQ:DXCM)
West Pharmaceutical Servi (N:WST)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.